MST1R
Basic information
Region (hg38): 3:49886902-49903873
Previous symbols: [ "RON", "PTK8", "SEA" ]
Links
Phenotypes
GenCC
Source:
- nasopharyngeal carcinoma, susceptibility to, 3 (Limited), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MST1R gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 13 | |||||
missense | 67 | 10 | 86 | |||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 67 | 19 | 16 |
Variants in MST1R
This is a list of pathogenic ClinVar variants found in the MST1R region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-49887339-G-A | not specified | Uncertain significance (Sep 27, 2021) | ||
3-49887356-C-A | MST1R-related disorder • not specified | Uncertain significance (Jul 14, 2021) | ||
3-49887369-A-G | not specified | Likely benign (Feb 28, 2023) | ||
3-49887381-G-A | Uncertain significance (-) | |||
3-49887468-G-T | not specified | Uncertain significance (Mar 02, 2023) | ||
3-49887507-T-C | MST1R-related disorder | Benign (Oct 21, 2019) | ||
3-49887514-G-A | Benign (Dec 31, 2019) | |||
3-49887518-C-T | not specified | Uncertain significance (May 13, 2024) | ||
3-49889957-C-T | not specified | Uncertain significance (Aug 04, 2023) | ||
3-49889960-C-T | not specified | Uncertain significance (Jun 17, 2024) | ||
3-49889961-G-A | not specified | Uncertain significance (Mar 07, 2023) | ||
3-49890005-C-A | not specified | Uncertain significance (Mar 25, 2024) | ||
3-49890005-C-T | not specified | Uncertain significance (May 30, 2024) | ||
3-49890035-T-A | not specified | Uncertain significance (Jun 17, 2024) | ||
3-49890070-G-T | MST1R-related disorder | Benign (Dec 16, 2019) | ||
3-49890531-G-A | not specified | Uncertain significance (Dec 07, 2021) | ||
3-49890546-G-A | not specified | Uncertain significance (Apr 11, 2023) | ||
3-49890552-C-T | not specified | Uncertain significance (Aug 08, 2022) | ||
3-49890553-G-A | not specified | Uncertain significance (Mar 28, 2024) | ||
3-49890576-C-G | not specified | Uncertain significance (Oct 06, 2023) | ||
3-49890601-C-T | not specified | Uncertain significance (Apr 10, 2023) | ||
3-49890602-G-A | Benign (Dec 31, 2019) | |||
3-49890603-C-T | not specified | Uncertain significance (Jan 31, 2024) | ||
3-49891261-G-A | not specified | Uncertain significance (Jan 26, 2022) | ||
3-49891263-G-A | not specified | Uncertain significance (Aug 02, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MST1R | protein_coding | protein_coding | ENST00000296474 | 20 | 16865 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
7.87e-37 | 0.00000480 | 124993 | 3 | 752 | 125748 | 0.00301 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.682 | 796 | 852 | 0.934 | 0.0000547 | 8943 |
Missense in Polyphen | 268 | 296.26 | 0.90461 | 3292 | ||
Synonymous | 1.41 | 326 | 360 | 0.905 | 0.0000229 | 3080 |
Loss of Function | -0.0592 | 55 | 54.5 | 1.01 | 0.00000297 | 578 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0211 | 0.0209 |
Ashkenazi Jewish | 0.00218 | 0.00218 |
East Asian | 0.00152 | 0.00152 |
Finnish | 0.00226 | 0.00222 |
European (Non-Finnish) | 0.00196 | 0.00195 |
Middle Eastern | 0.00152 | 0.00152 |
South Asian | 0.00177 | 0.00173 |
Other | 0.000816 | 0.000815 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding to MST1 ligand. Regulates many physiological processes including cell survival, migration and differentiation. Ligand binding at the cell surface induces autophosphorylation of RON on its intracellular domain that provides docking sites for downstream signaling molecules. Following activation by ligand, interacts with the PI3-kinase subunit PIK3R1, PLCG1 or the adapter GAB1. Recruitment of these downstream effectors by RON leads to the activation of several signaling cascades including the RAS-ERK, PI3 kinase-AKT, or PLCgamma-PKC. RON signaling activates the wound healing response by promoting epithelial cell migration, proliferation as well as survival at the wound site. Plays also a role in the innate immune response by regulating the migration and phagocytic activity of macrophages. Alternatively, RON can also promote signals such as cell migration and proliferation in response to growth factors other than MST1 ligand. {ECO:0000269|PubMed:18836480, ECO:0000269|PubMed:7939629, ECO:0000269|PubMed:9764835}.;
- Disease
- DISEASE: Nasopharyngeal carcinoma, 3 (NPCA3) [MIM:617075]: A form of nasopharyngeal carcinoma, a malignant neoplasm that originates in the nasopharyngeal epithelium and includes 4 subtypes: keratinizing squamous cell, non-keratinizing, basaloid squamous cell, and papillary adenocarcinoma. {ECO:0000269|PubMed:26951679}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
- Pathway
- Signal Transduction;Alpha6Beta4Integrin;a6b1 and a6b4 Integrin signaling;Signaling by MST1;Signaling by Receptor Tyrosine Kinases;amb2 Integrin signaling
(Consensus)
Recessive Scores
- pRec
- 0.154
Intolerance Scores
- loftool
- 0.857
- rvis_EVS
- -1.78
- rvis_percentile_EVS
- 2.29
Haploinsufficiency Scores
- pHI
- 0.326
- hipred
- N
- hipred_score
- 0.352
- ghis
- 0.513
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.749
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mst1r
- Phenotype
- immune system phenotype; liver/biliary system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; hematopoietic system phenotype; endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype;
Zebrafish Information Network
- Gene name
- mst1rb
- Affected structure
- bone mineralization
- Phenotype tag
- abnormal
- Phenotype quality
- delayed
Gene ontology
- Biological process
- defense response;signal transduction;transmembrane receptor protein tyrosine kinase signaling pathway;single fertilization;positive regulation of cell population proliferation;response to virus;Wnt signaling pathway;peptidyl-tyrosine phosphorylation;macrophage colony-stimulating factor signaling pathway;positive regulation of MAP kinase activity;innate immune response;hepatocyte growth factor receptor signaling pathway;positive regulation of protein kinase B signaling
- Cellular component
- stress fiber;vacuole;plasma membrane;integral component of plasma membrane;cell surface;receptor complex
- Molecular function
- transmembrane receptor protein tyrosine kinase activity;macrophage colony-stimulating factor receptor activity;protein binding;ATP binding;Wnt-protein binding;enzyme binding